Neoplams
7
1
3
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Using Virtual Reality During PICC and PICC-PORT Placement in Cancer Patients
The Phase I Study of SIG001 Antibody on Cancer Therapy.
Plyometric Strength-Endurance Exercise in Breast Cancer
Community-Based Exercise Oncology: Real-World Evidence of High Adherence, Improved Quality of Life and Cost-Effectiveness Across the Cancer Continuum
xDRIVE for Florida-based Cancer Patients
Pilot Study of Coil Arrays in Patients With Advanced Solid Tumor Malignancies
Retrospective Non-interventional Analysis of Opportunistic Infections in Immunocompromised and Frail Patients